Rowan E Chapman, a director at $NTRA, sold 2,750 shares of the company on 08-28-2025 for an estimated $459,222. We received data on the trade from a recent SEC filing. This was a sale of approximately 31.4% of their shares of this class of stock. Following this trade, they now own 6,015 shares of this class of $NTRA stock.
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 220 times in the past 6 months. Of those trades, 0 have been purchases and 220 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 30 sales selling 159,257 shares for an estimated $22,983,648.
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 15 sales selling 108,563 shares for an estimated $16,435,622.
- JONATHAN SHEENA has made 0 purchases and 73 sales selling 37,328 shares for an estimated $5,714,593.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 12 sales selling 27,161 shares for an estimated $4,439,339.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 32 sales selling 29,549 shares for an estimated $4,373,949.
- GAIL BOXER MARCUS has made 0 purchases and 22 sales selling 22,795 shares for an estimated $3,469,952.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 25 sales selling 19,024 shares for an estimated $2,745,637.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 10 sales selling 7,012 shares for an estimated $1,043,344.
- ROWAN E CHAPMAN sold 2,750 shares for an estimated $459,222
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTRA Hedge Fund Activity
We have seen 373 institutional investors add shares of $NTRA stock to their portfolio, and 330 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 3,263,822 shares (+44.3%) to their portfolio in Q2 2025, for an estimated $551,390,088
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,650,073 shares (+15.7%) to their portfolio in Q2 2025, for an estimated $278,763,332
- CITADEL ADVISORS LLC removed 1,301,513 shares (-61.3%) from their portfolio in Q2 2025, for an estimated $219,877,606
- KYNAM CAPITAL MANAGEMENT, LP removed 1,167,570 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $197,249,275
- CAPITAL WORLD INVESTORS added 1,013,229 shares (+255.6%) to their portfolio in Q2 2025, for an estimated $171,174,907
- LORD, ABBETT & CO. LLC removed 736,644 shares (-48.4%) from their portfolio in Q2 2025, for an estimated $124,448,637
- POINTSTATE CAPITAL LP removed 615,287 shares (-81.4%) from their portfolio in Q2 2025, for an estimated $103,946,585
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NTRA Congressional Stock Trading
Members of Congress have traded $NTRA stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 07/22.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$NTRA Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stephens & Co. issued a "Overweight" rating on 08/15/2025
- Piper Sandler issued a "Overweight" rating on 08/11/2025
- RBC Capital issued a "Outperform" rating on 08/08/2025
- Barclays issued a "Overweight" rating on 08/08/2025
- Evercore ISI Group issued a "Outperform" rating on 07/28/2025
- UBS issued a "Buy" rating on 05/09/2025
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
$NTRA Price Targets
Multiple analysts have issued price targets for $NTRA recently. We have seen 6 analysts offer price targets for $NTRA in the last 6 months, with a median target of $214.0.
Here are some recent targets:
- Mason Carrico from Stephens & Co. set a target price of $183.0 on 08/15/2025
- David Westenberg from Piper Sandler set a target price of $220.0 on 08/11/2025
- Luke Sergott from Barclays set a target price of $210.0 on 08/08/2025
- Conor McNamara from RBC Capital set a target price of $255.0 on 08/08/2025
- Daniel Markowitz from Evercore ISI Group set a target price of $170.0 on 07/28/2025
- Elizabeth Garcia from UBS set a target price of $218.0 on 05/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
